Co-Diagnostics, Inc.
CODX
$0.2981
-$0.002-0.67%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 567.60K | 770.00K | 675.90K | 605.50K | 642.20K |
| Total Other Revenue | 2.93M | 3.15M | 6.65M | 8.53M | 6.04M |
| Total Revenue | 3.50M | 3.92M | 7.32M | 9.14M | 6.68M |
| Cost of Revenue | 786.20K | 999.10K | 3.71M | 3.67M | 3.92M |
| Gross Profit | 2.71M | 2.92M | 3.61M | 5.47M | 2.76M |
| SG&A Expenses | 19.59M | 20.64M | 19.92M | 19.63M | 20.90M |
| Depreciation & Amortization | 1.33M | 1.38M | 1.33M | 1.28M | 1.25M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 41.87M | 44.00M | 47.32M | 47.84M | 49.69M |
| Operating Income | -38.37M | -40.08M | -40.00M | -38.70M | -43.02M |
| Income Before Tax | -35.81M | -37.58M | -37.38M | -35.81M | -39.38M |
| Income Tax Expenses | 46.60K | 57.40K | 3.90M | 1.76M | -495.10K |
| Earnings from Continuing Operations | -35.86 | -37.64 | -41.28 | -37.57 | -38.89 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -35.86M | -37.64M | -41.28M | -37.57M | -38.89M |
| EBIT | -38.37M | -40.08M | -40.00M | -38.70M | -43.02M |
| EBITDA | -37.05M | -38.70M | -38.67M | -37.42M | -41.77M |
| EPS Basic | -1.16 | -1.24 | -1.38 | -1.27 | -1.32 |
| Normalized Basic EPS | -0.76 | -0.81 | -0.81 | -0.79 | -0.89 |
| EPS Diluted | -1.17 | -1.24 | -1.38 | -1.27 | -1.32 |
| Normalized Diluted EPS | -0.76 | -0.81 | -0.81 | -0.79 | -0.89 |
| Average Basic Shares Outstanding | 123.54M | 121.34M | 119.93M | 118.80M | 117.76M |
| Average Diluted Shares Outstanding | 123.54M | 121.34M | 119.93M | 118.80M | 117.76M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |